Table of Contents

• K W Brewer,
• H P Chase,
• S Owen,
• and S K Garg

Slicing the pie. Correlating HbA--values with average blood glucose values in a pie chart form.

• K P Tercyak, Jr,
• S B Johnson,
• K A Kirkpatrick,
• and J H Silverstein

Offering a randomized trial of intensive therapy for IDDM to adolescents. Reasons for refusal, patient characteristics, and recruiter effects.

• F A Kemperman,
• J Silberbusch,
• E H Slaats,
• A M Prins,
• J A Weber,
• R T Krediet,
• and L Arisz

Estimation of the glomerular filtration rate in NIDDM patients from plasma creatinine concentration after cimetidine administration.

• E Bonora,
• J Willeit,
• S Kiechl,
• F Oberhollenzer,
• G Egger,
• R Bonadonna,
• and M Muggeo

U-shaped and J-shaped relationships between serum insulin and coronary heart disease in the general population. The Bruneck Study.

• M J Rosenthal,
• M Fajardo,
• S Gilmore,
• J E Morley,
• and B D Naliboff

Hospitalization and mortality of diabetes in older adults. A 3-year prospective study.

• B E Klein,
• R Klein,
• and S E Moss

Self-rated health and diabetes of long duration. The Wisconsin Epidemiologic Study of Diabetic Retinopathy.

• P M Trief,
• W Grant,
• K Elbert,
• and R S Weinstock

Family environment, glycemic control, and the psychosocial adaptation of adults with diabetes.

• C S Levetan,
• M Passaro,
• K Jablonski,
• M Kass,
• and R E Ratner

Unrecognized diabetes among hospitalized patients.

• M Wroblewski,
• A Gottsater,
• F Lindgarde,
• P Fernlund,
• and G Sundkvist

Gender, autoantibodies, and obesity in newly diagnosed diabetic patients aged 40-75 years.

• K Matsumoto,
• M Yano,
• S Miyake,
• Y Ueki,
• Y Yamaguchi,
• S Akazawa,
• and Y Tominaga

Effects of voglibose on glycemic excursions, insulin secretion, and insulin sensitivity in non-insulin-treated NIDDM patients.

• E S Kilpatrick,
• P W Maylor,
• and B G Keevil

Biological variation of glycated hemoglobin. Implications for diabetes screening and monitoring.

• P Gillery,
• G Dumont,
• and A Vassault

Evaluation of GHb assays in France by national quality control surveys.

• M D Enderle,
• N Benda,
• R M Schmuelling,
• H U Haering,
• and M Pfohl

Preserved endothelial function in IDDM patients, but not in NIDDM patients, compared with healthy subjects.

• T W van Haeften,
• S Dubbeldam,
• M L Zonderland,
• and D W Erkelens

Insulin secretion in normal glucose-tolerant relatives of type 2 diabetic subjects. Assessments using hyperglycemic glucose clamps and oral glucose tolerance tests.

• A Korzon-Burakowska,
• D Hopkins,
• K Matyka,
• J Lomas,
• A Pernet,
• I Macdonald,
• and S Amiel

Effects of glycemic control on protective responses against hypoglycemia in type 2 diabetes.

• R O Estacio,
• J G Regensteiner,
• E E Wolfel,
• B Jeffers,
• M Dickenson,
• and R W Schrier

The association between diabetic complications and exercise capacity in NIDDM patients.

Economic consequences of diabetes mellitus in the U.S. in 1997. American Diabetes Association.

Consensus Development Conference on Insulin Resistance. 5-6 November 1997. American Diabetes Association.

• Z T Bloomgarden

American Diabetes Association annual meeting, 1997, and the Teczem Consultant Meeting. Diabetic nephropathy.

• N Sakane,
• N Onishi,
• M Katamura,
• H Sato,
• M Takamasu,
• and T Yoshida

Cifenline succinate and dementia in an elderly NIDDM patient.

• T J Orchard

Hyperglycemia and coronary heart disease.

• S Rode,
• C Favre,
• and C Thivolet

Diabetic mastopathy. A frequent source of confusion with lobular breast carcinoma.

• R A Hegele,
• T M Wolever,
• A J Hanley,
• S B Harris,
• and B Zinman

Methylene tetrahydrofolate reductase gene, dietary folate, NIDDM, and atherosclerosis in Canadian Oji-Cree.

• J Minamikawa,
• M Yamauchi,
• S Tanaka,
• and H Koshiyama

Carotid arterial intimal-medial thickening and plaque formation in NIDDM.

• P M Livingston,
• C A Wood,
• M Butler,
• J Oh,
• J E Keefe,
• and H R Taylor

General practitioners are the most important conveyors of information to their patients regarding diabetic retinopathy.

• P Bélicar and
• V Lassmann-Vague

Local adverse events associated with long-term treatment by implantable insulin pumps. The French EVADIAC Study Group experience. Evaluation dans le Diabète du Traitement par Implants Actifs.

• M Cantero,
• T Parra,
• and J R Conejo

Increased hydrogen peroxide formation in polymorphonuclear leukocytes of IDDM patients.